Cargando…

Controlled human malaria infection (CHMI) outcomes in Kenyan adults is associated with prior history of malaria exposure and anti-schizont antibody response

BACKGROUND: Individuals living in endemic areas acquire immunity to malaria following repeated parasite exposure. We sought to assess the controlled human malaria infection (CHMI) model as a means of studying naturally acquired immunity in Kenyan adults with varying malaria exposure. METHODS: We ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kapulu, Melissa C., Kimani, Domtila, Njuguna, Patricia, Hamaluba, Mainga, Otieno, Edward, Kimathi, Rinter, Tuju, James, Sim, B. Kim Lee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785382/ https://www.ncbi.nlm.nih.gov/pubmed/35073864 http://dx.doi.org/10.1186/s12879-022-07044-8

Ejemplares similares

Controlled Human Malaria Infection in Semi-Immune Kenyan Adults (CHMI-SIKA): a study protocol to investigate in vivo Plasmodium falciparum malaria parasite growth in the context of pre-existing immunity
por: Kapulu, Melissa C., et al.
Publicado: (2019)

Safety and PCR monitoring in 161 semi-immune Kenyan adults following controlled human malaria infection
por: Kapulu, Melissa C., et al.
Publicado: (2021)

Deliberately infecting healthy volunteers with malaria parasites: Perceptions and experiences of participants and other stakeholders in a Kenyan‐based malaria infection study
por: Jao, Irene, et al.
Publicado: (2020)

Phagocytosis of Plasmodium falciparum ring-stage parasites predicts protection against malaria
por: Musasia, Fauzia K., et al.
Publicado: (2022)

Perceptions and acceptability of the controlled human malaria infection (CHMI) model in The Gambia: a qualitative study
por: Dabira, Edgard Diniba, et al.
Publicado: (2023)

Malaria attributable fractions with changing transmission intensity: Bayesian latent class vs logistic models
por: Mwai, Kennedy, et al.
Publicado: (2022)

Undertaking Community Engagement for a Controlled Human Malaria Infection Study in Kenya: Approaches and Lessons Learnt
por: Mumba, Noni, et al.
Publicado: (2022)

Controlled human malaria infection in Kenyan adults: A safe model that could accelerate assessment of novel drugs and vaccines in malaria endemic populations
por: Hodgson, Susanne, et al.
Publicado: (2014)

CD4(+) T Cell Responses to the Plasmodium falciparum Erythrocyte Membrane Protein 1 in Children with Mild Malaria
por: Gitau, Evelyn N., et al.
Publicado: (2014)

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection
por: Hodgson, Susanne H., et al.
Publicado: (2014)

Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction
por: Mogeni, Polycarp, et al.
Publicado: (2017)

Distinct kinetics of antibodies to 111 Plasmodium falciparum proteins identifies markers of recent malaria exposure
por: Yman, Victor, et al.
Publicado: (2022)

Ethical considerations in Controlled Human Malaria Infection studies in low resource settings: Experiences and perceptions of study participants in a malaria Challenge study in Kenya
por: Njue, Maureen, et al.
Publicado: (2018)

Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum
Publicado: (1985)

Controlled Human Malaria Infection (CHMI) differentially affects cell-mediated and antibody responses to CSP and AMA1 induced by adenovirus vaccines with and without DNA-priming
por: Sedegah, Martha, et al.
Publicado: (2015)

Decorticate, decerebrate and opisthotonic posturing and seizures in Kenyan children with cerebral malaria
por: Idro, Richard, et al.
Publicado: (2005)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Schizont transcriptome variation among clinical isolates and laboratory-adapted clones of the malaria parasite Plasmodium falciparum
por: Tarr, Sarah J., et al.
Publicado: (2018)

Malaria Parasite Schizont Egress Antigen-1 Plays an Essential Role in Nuclear Segregation during Schizogony
por: Perrin, Abigail J., et al.
Publicado: (2021)

Malaria hotspots defined by clinical malaria, asymptomatic carriage, PCR and vector numbers in a low transmission area on the Kenyan Coast
por: Kangoye, David Tiga, et al.
Publicado: (2016)

Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure
por: Abdi, Abdirahman I., et al.
Publicado: (2017)

PfATP4 inhibitors in the Medicines for Malaria Venture Malaria Box and Pathogen Box block the schizont-to-ring transition by inhibiting egress rather than invasion
por: Barnes, Claudia B. G., et al.
Publicado: (2022)

Arterolane–piperaquine–mefloquine versus arterolane–piperaquine and artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a single-centre, open-label, randomised, non-inferiority trial
por: Hamaluba, Mainga, et al.
Publicado: (2021)

Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children
por: Booth, Mark, et al.
Publicado: (2004)

Sensitivity of fever for diagnosis of clinical malaria in a Kenyan area of unstable, low malaria transmission
por: Mutanda, Albino L, et al.
Publicado: (2014)

Quantitative protein expression profiling reveals extensive post-transcriptional regulation and post-translational modifications in schizont-stage malaria parasites
por: Foth, Bernardo J, et al.
Publicado: (2008)

FEEDBACK OF RESEARCH FINDINGS FOR VACCINE TRIALS: EXPERIENCES FROM TWO MALARIA VACCINE TRIALS INVOLVING HEALTHY CHILDREN ON THE KENYAN COAST
por: Gikonyo, Caroline, et al.
Publicado: (2013)

Prevalence and associated determinants of malaria parasites among Kenyan children
por: Sultana, Marufa, et al.
Publicado: (2017)

Proteomic analysis of the Theileria annulata schizont
por: Witschi, M., et al.
Publicado: (2013)

Developing Gametocytes and Schizonts of Plasmodium Falciparum
Publicado: (1944)

Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children
por: Booth, Mark, et al.
Publicado: (2004)

Acute seizures attributable to falciparum malaria in an endemic area on the Kenyan coast
por: Kariuki, Symon M., et al.
Publicado: (2011)

Observational study: 27 years of severe malaria surveillance in Kilifi, Kenya
por: Njuguna, Patricia, et al.
Publicado: (2019)

protGear: A protein microarray data pre-processing suite
por: Mwai, Kennedy, et al.
Publicado: (2021)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 (E) on blood stage immunity in young Kenyan children
por: Ndungu, Francis M., et al.
Publicado: (2019)

A Plasmodium falciparum FcB1-schizont-EST collection providing clues to schizont specific gene structure and polymorphism
por: Florent, Isabelle, et al.
Publicado: (2009)

Vaccine candidate discovery for the next generation of malaria vaccines
por: Tuju, James, et al.
Publicado: (2017)

Modelling dynamic change of malaria transmission in holoendemic setting (Dielmo, Senegal) using longitudinal measures of antibody prevalence to Plasmodium falciparum crude schizonts extract
por: Niass, Oumy, et al.
Publicado: (2017)

Incidence of chikungunya virus infections among Kenyan children with neurological disease, 2014–2018: A cohort study
por: Nyamwaya, Doris K., et al.
Publicado: (2022)

Malaria and Chikungunya Detected Using Molecular Diagnostics Among Febrile Kenyan Children
por: Waggoner, Jesse, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_d3v0uhfvith5ktunivuf6ju735